Article
Predictive value of RAD51 on the survival and drug responsiveness of ovarian cancer
5 May 2021
Abstract excerpt
BACKGROUND: Ovarian cancer has greatly endangered and deteriorated female health conditions worldwide. Refinement of predictive biomarkers could enable patient stratification and help optimize disease management. METHODS: RAD51 expression profile, target-disease associations, and fitness scores of RAD51 were analyzed in ovarian cancer using bioinformatic analysis. To further identify its role, gene enrichment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
